Successful Treatment with Low-dose Crizotinib in a Patient with <i>ROS1</i>-rearranged Lung Cancer Who Developed Crizotinib-induced Heart Failure-Reference-Cited by-同舟云学术

Successful Treatment with Low-dose Crizotinib in a Patient with <i>ROS1</i>-rearranged Lung Cancer Who Developed Crizotinib-induced Heart Failure

Published:2023-01-15 Issue:2 Volume:62 Page:281-284
ISSN:0918-2918
Container-title:Internal Medicine
language:en
Short-container-title:Intern. Med.

Author:

Hashimoto Takahiko¹,Takahashi Kosuke²,Ota Sachiko²,Okumura Nobumasa³,Kondo Haruka²,Fukatsu Asuki²,Hara Toru²

Affiliation:

1. Department of Respiratory Medicine, Nagoya University Graduate School of Medicine, Japan

2. Department of Respiratory Medicine, Anjo Kosei Hospital, Japan

3. Disease Control and Prevention Center, National Center for Global Health and Medicine, Japan

Publisher

Japanese Society of Internal Medicine

Subject

General Medicine,Internal Medicine

Link

https://www.jstage.jst.go.jp/article/internalmedicine/62/2/62_9157-21/_pdf

Reference14 articles.

1. 1. Gainor JF, Shaw AT. Novel targets in non-small cell lung cancer, ROS1 and RET fusions. Oncologist 18: 865-875, 2013.

2. 2. Shaw AT, Ou SH, Bang YJ, et al. Crizotinib in ROS1-rearranged non-small-cell lung cancer. N Engl J Med 371: 1963-1971, 2014.

3. 3. Wu YL, Yang JC, Kim DW, et al. Phase II study of crizotinib in East Asian patients with ROS1-positive advanced non-small-cell lung cancer. J Clin Oncol 36: 1405-1411, 2018.

4. 4. Tartarone A, Gallucci G, Lazzari C, Lerose R, Lombardi L, Aieta M. Crizotinib-induced cardiotoxicity, the importance of a proactive monitoring and management. Future Oncol 1: 2043-2048, 2015.

5. 5. Full prescribing information. Xalkori [Internet]. [cited 2022 Apr 1]. Available from: https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/202570s030lbl.pdf.

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Oxyphenbutazone ameliorates carfilzomib induced cardiotoxicity in rats via inhibition of oxidative free radical burst and NF-κB/IκB-α pathway;Saudi Pharmaceutical Journal;2024-01